Continued Early Intervention for Recent-Onset Schizophrenia

This study has been terminated.
Sponsor:
Collaborator:
The Research Council of Norway
Information provided by:
Norwegian University of Science and Technology
ClinicalTrials.gov Identifier:
NCT00184509
First received: September 15, 2005
Last updated: NA
Last verified: September 2005
History: No changes posted
  Purpose

The purpose of this study was to determine whether outreach integrated treatment of first episode schizophrenia was more effecive than standard outpatient treatment.


Condition Intervention Phase
Schizophrenia
Behavioral: integrated psychosocial treatment (behavior)
Phase 3

Study Type: Interventional
Study Design: Allocation: Randomized
Endpoint Classification: Efficacy Study
Intervention Model: Single Group Assignment
Masking: Open Label
Primary Purpose: Treatment
Official Title: Continued Early Intervention for Recent-Onset Schizophrenia. A Randomized Controlled Study.

Resource links provided by NLM:


Further study details as provided by Norwegian University of Science and Technology:

Primary Outcome Measures:
  • Rehospitalizations and psychotic relapse at two years

Secondary Outcome Measures:
  • Psychopathology, psychosocial changes, functioning, antipsychotic medication

Estimated Enrollment: 50
Study Start Date: February 1993
Estimated Study Completion Date: May 1998
Detailed Description:

Early intervention for schizophrenia has spawned considerable enthusiasm among clinicians without solid research evidence to suport its benefits and costs. The present study is a random-controlled study of integrated biomedical and psychosocial treatment on a population of recent-onset cases.

Comparison(s): 50 consecutive referrals with schizophrenic disorders of less than two years duration were allocated randomly to a comprehensive model of integrated treatment or standard care for two years. Main outcome measures was psychopathology, psychosocial functioning and hospital admissions.

  Eligibility

Ages Eligible for Study:   18 Years to 35 Years
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • first-episode schizophrenia

Exclusion Criteria:

  • acute psychosis
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00184509

Locations
Norway
Norwegian University of Science and Technology
Trondheim, Norway, N-7000
Sponsors and Collaborators
Norwegian University of Science and Technology
The Research Council of Norway
Investigators
Study Director: K. Gunnar Gøtestam, MD Norwegian University of Science and Technology
  More Information

No publications provided by Norwegian University of Science and Technology

Additional publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
ClinicalTrials.gov Identifier: NCT00184509     History of Changes
Other Study ID Numbers: SHDIR-1992-1995; NFR-1997-1999
Study First Received: September 15, 2005
Last Updated: September 15, 2005
Health Authority: Norway: Norwegian Social Science Data Services

Keywords provided by Norwegian University of Science and Technology:
schizophrenia
psychosocial treatment
outcome

Additional relevant MeSH terms:
Schizophrenia
Schizophrenia and Disorders with Psychotic Features
Mental Disorders

ClinicalTrials.gov processed this record on April 17, 2014